Work Here?
Sleuth Insights
Work Here?
AI-powered biopharma intelligence platform for decision-making
Sleuth Insights
Work Here?
AI-powered biopharma intelligence platform for decision-making
Overview
Sleuth Insights builds an AI-powered biopharma intelligence platform for strategic decision-making in pharmaceutical research and development. It combines a proprietary knowledge graph with over 100 million pre-linked data points from public and proprietary sources, covering drugs, clinical trials, deals, targets, indications, regulatory filings, transcripts, reports, news, and patents. Users can access done-for-you intelligence from Sleuth’s analysts or query the knowledge graph in natural language to export findings and build dashboards, with real-time hypothesis testing to identify related trials. The platform differentiates itself through its extensive, continuously validated data graph and the integration of AI querying with analyst-driven analysis, aiming to speed up data gathering and interpretation for commercial diligence and investment strategies under an annual retainer pricing model.
About Sleuth Insights
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Biotechnology
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Los Angeles, California
Founded
2023
Get referred to Sleuth Insights
See people who can refer or advise you
Simplify's Take
What believers are saying
- April 21, 2026 seed funding of $8 million funds engineering and data expansion.
- Sleuth says dozens of biopharma companies already use it, including Daiichi Sankyo.
- Its July 2026 site emphasizes traceability, conference coverage, and China-pipeline monitoring, strengthening enterprise fit.
What critics are saying
- Clarivate, IQVIA, Citeline, and AlphaSense dominate budgets and procurement decisions in 2026.
- Biopharma AI rivals like Ferma and Pienomial attack Sleuth's exact workflow with vertical focus.
- If its analyst-heavy delivery scales slowly, Sleuth becomes a services business, not software.
What makes Sleuth Insights unique
- April 2026 launch: Sleuth pairs a biopharma knowledge graph with executive-ready analysis.
- Sleuth claims over a billion relationships and source-traced answers across biopharma datasets.
- Daiichi Sankyo and Epana Bio usage suggests demand beyond a single niche.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Company Equity
Hybrid Work Options
Remote Work Options
Growth & Insights and Company News
6 month growth
↑ 17%1 year growth
↑ 25%2 year growth
↑ 25%According to filings with the U.S. Securities and Exchange Commission, Sleuth Insights, Inc. is raising up to $7,914,999.00 in new funding. The federal securities law requires the notice to be filed by companies that have
Sleuth Insights is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Sleuth Insights
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Biotechnology
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Los Angeles, California
Founded
2023
Sleuth Insights is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today